Bolt Biotherapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
BOLT on Nasdaq
Location
900 Chesapeake Drive, Redwood City, California

Insiders trading volume in the past year

Bolt Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Capital VIII, LLC More than 10% owner $5.44 M -$83 K -1.5% Nov 21, 2023
Holdings A/S Novo More than 10% owner $3.52 M Jul 13, 2022
Edgar Engleman Director $1.97 M -$176 K -8.22% Nov 29, 2023
Edith A. Perez Chief Medical Officer $36.5 K +$1.96 K +5.67% Mar 4, 2024
William P. Quinn Chief Financial Officer $34.5 K +$9.08 K +35.8% Mar 4, 2024
Sarah Nemec Principal Accounting Officer $10.8 K May 15, 2024
Randall C. Schatzman Chief Executive Officer, Director $10.1 K +$1.96 K +24.1% Mar 4, 2024
Grant Yonehiro Chief Business Officer $6.97 K +$1.96 K +39% Mar 4, 2024
David Dornan Chief Scientific Officer Feb 18, 2022
Brian O'callaghan Director Jun 12, 2023
Laporte Kathleen Director Jun 12, 2023
Laura Berner Director Jun 12, 2023
Frank D. Lee Director Jun 12, 2023
James Healy Director Jun 12, 2023
Richard A. Miller Director Jun 12, 2023
Mahendra Shah Director Jun 12, 2023
Nicole Onetto Director Jun 12, 2023

Recent Insider Transactions by Companies or Individuals for Bolt Biotherapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership